Remedium Bio is a gene therapy company focused on the development of treatments for large unmet clinical needs. To enable this, we developed a revolutionary gene therapy platform technology, which enables safe, effective, and durable delivery of therapeutic genes while allowing for simple post-treatment dose adjustment. The Prometheus™ adjustable gene therapy platform is able to safely and durably replace multi-injection subcutaneously administered biologics, with a single treatment, at a fraction of the cost, and without genetic integration. Our lead product is a disease-modifying treatment for Osteoarthritis that is based on the only clinically validated chondro-regenerative mechanism. Remedium’s pipeline includes gene therapy treatments in the fields of Weight Loss, Type 2 Diabetes, and Stroke.
Modalities and Indications
Grounded in the Prometheus™ adjustable gene therapy platform, our pipeline consists of a broad range of regenerative therapeutics targeting diseases of aging and large clinical unmet needs. Each therapeutic candidate is developed by modularly applying proven fundamentals in novel ways, to treat well-characterized pathologies.
There is so much to life
The only worthy purpose is saving it!
Remedium therapies are based on proven fundamental components including clinically validated targets, commercial delivery vectors, and time-tested manufacturing technologies.
The technology is then applied to treating disease using a fundamentally novel, patent pending approach. An approach, uniquely matched specifically with the target condition.
The Prometheus platform has truly infinite potential, enabling the replacement of a broad range of subcutaneously delivered biologics, with a single, adjustable-dose gene therapy.
Get In Touch
We are always interested in starting a new conversation and are looking forward to hearing from you. Thank you in advance for your inquiry and please have a wonderful day!
1116 Great Plain Ave, Suite 203
P: +1 (978) 467 5217